Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News

Pharma News

COVID-19 lockdown in India hub leaves pharmas scrambling to keep up supply
COVID-19 lockdown in India hub leaves pharmas scrambling to keep up supply
With a major Indian production hub now locked down in a COVID-19 containment zone, the spotlight on pharma's emerging markets suppliers will likely shine even hotter.
Merck KGaA amps up in gene therapy with $110M viral vector manufacturing boost
Merck KGaA amps up in gene therapy with $110M viral vector manufacturing boost
Merck KGaA and subsidiary MilliporeSigma are doubling down on their gene therapy bets with a hefty nine-figure investment into expanded viral vector production.
Astellas Announces Acquisition of Nanna
Astellas Announces Acquisition of Nanna
TOKYO and CAMBRIDGE (UK), April 21, 2020 - Astellas Pharma Inc.
FDA Approves First New Drug Under International Collaboration, A Treatment Option for Patients with HER2-Positive Metastatic Breast Cancer
FDA Approves First New Drug Under International Collaboration, A Treatment Option for Patients with HER2-Positive Metastatic Breast Cancer
Today, as part of Project Orbis, the U.
FDA Approves First Targeted Treatment for Patients with Cholangiocarcinoma, a Cancer of Bile Ducts
FDA Approves First Targeted Treatment for Patients with Cholangiocarcinoma, a Cancer of Bile Ducts
Today, the U.
Cannabis Formulation for the Treatment of Colon Cancer
Cannabis Formulation for the Treatment of Colon Cancer
TEL AVIV, Israel and BETHESDA, Maryland, /PRNewswire/ -- Cannabics Pharmaceuticals Inc.
Genentech, Novo Nordisk and AbbVie top the list of best workplaces in biopharma
Genentech, Novo Nordisk and AbbVie top the list of best workplaces in biopharma
Biopharma companies all vow to help patients, but how do they fare in creating healthy workplace environments for their employees?Roche’s Genentech, Novo Nordisk and AbbVie ranked as the top 3 on Fo...
Don't count on a COVID-19 vaccine for at least 5 years, says AI-based forecast
Don't count on a COVID-19 vaccine for at least 5 years, says AI-based forecast
Ever since President Donald Trump said last month that a COVID-19 vaccine could be ready in 12 to 18 months, Wall Street analysts have been warning that the real timeline is likely to be longer, even ...
Kaneka Agrees to Supply Active Pharmaceutical Ingredients for Avigan® Tablet
Kaneka Agrees to Supply Active Pharmaceutical Ingredients for Avigan® Tablet
Kaneka Corporation (President.
Cancer drug resistance study raises immune red flags
Cancer drug resistance study raises immune red flags
JUPITER, Fla.
New data back long-term use of Novartis' Aimovig in migraine
New data back long-term use of Novartis' Aimovig in migraine
New real-world data for Novartis' Aimovig (erenumab) published in Neurology support the long-term safety and efficacy of the drug among chronic and episodic migraine patients.
Chi-Med's surufatinib bags US fast track designations
Chi-Med's surufatinib bags US fast track designations
US regulators have granted two fast track designations for the development of Chi-Med's surufatinib for the treatment of both advanced and progressive pancreatic neuroendocrine tumours (NET...
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand